Last reviewed · How we verify
NCT06578169
Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study
trial testing Hormonal Therapy Agent in Asthma in 300 participants. Not yet recruiting.
1 September 2027
Quick facts
| Lead sponsor | Copenhagen University Hospital, Hvidovre |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 September 2024 |
| Primary completion | 1 September 2027 |
| Estimated completion | 1 September 2027 |
Drugs / interventions tested
- Hormonal Therapy Agent — full drug profile →
Conditions studied
- Asthma — all drugs for Asthma →
Sponsor
Copenhagen University Hospital, Hvidovre
Who can join
Adults 18 to 75, female only, with Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The project aims to investigate the effect of female sex hormone treatment (both contraceptive treatment and hormone therapy during menopause) on bronchial hyperreactivity in adult women. The study is a prospective cohort study involving 300 women, examining airway responsiveness before and after the initiation of hormone treatment, whether as hormone therapy in menopause or contraceptive treatment. Participants will be recruited from general practitioners in the Capital Region of Denmark. Lung function, bronchial hyperreactivity, airway inflammation, and body composition will be assessed before and after hormone treatment. Blood samples will also be collected and stored for later analysis of inflammation markers. The study will include women aged 18 to 75 who are about to begin hormone treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06578169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hormonal Therapy Agent
Trials testing the same drug.
- NCT06510647 — Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis. · recruiting
- NCT05110391 — Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy · completed
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other Copenhagen University Hospital, Hvidovre trials
Trials by the same sponsor.
- NCT07321379 — Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour · NA · not yet recruiting
- NCT07067060 — Risk of Serious Adverse Events Following Unsupervised vs Supervised Rehabilitation After Knee Arthroplasty · not yet recruiting
- NCT06967324 — GRACE - Graduated Response for Advanced COPD With Enhanced Support · NA · recruiting
- NCT06682260 — Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure · Phase 4 · completed
- NCT06866496 — Optimized Remission in Alcohol-related Liver Cirrhosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06578169 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Copenhagen University Hospital, Hvidovre
- Last refreshed: 29 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06578169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing